Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00128128 · ClinicalTrials.gov registry record · Phase 2
Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections
A Phase 2 study of Urinary Tract Infections, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 176
- Enrollment target
- 2
- Study locations
NCT00128128 is a Phase 2 study of Urinary Tract Infections that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 176 participants, below the 453-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00128128, a Phase 2 study of Urinary Tract Infections, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 176 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will determine whether cranberry juice is effective in reducing recurrent urinary tract infections (UTIs) in women who have had a UTI within the past year.
Conditions Studied
Interventions
- DRUG Cranberry juice cocktail
Study Locations (2)
Connecticut
- Yale New Haven Hospital - New Haven
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00128128
The ClinicalTrials.gov registry entry for NCT00128128 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (61% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 1 intervention - of which Cranberry juice cocktail is the first listed.
NCT00128128 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Washington.
Frequently Asked Questions
What is clinical trial NCT00128128 about?
NCT00128128 is a clinical study titled "Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections". This study will determine whether cranberry juice is effective in reducing recurrent urinary tract infections (UTIs) in women who have had a UTI within the past year.
What is the current status of trial NCT00128128?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 176 participants. The study started on 2005-08. Estimated completion is 2009-06.
What conditions does trial NCT00128128 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
What interventions are being tested in trial NCT00128128?
The interventions under investigation include: Cranberry juice cocktail (DRUG).
Who is sponsoring clinical trial NCT00128128?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00128128 being conducted?
This trial has 2 study locations across Connecticut, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
RECRUITING · Phase 2
-
Cranberry Juice for Treatment of Urinary Tract Infections
COMPLETED · Phase 2
-
UTI Prophylaxis Using Bacterial Interference Following SCI
COMPLETED · Phase 2
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.